Preliminary Outcomes With Luxlife™ Full Range Of Vision Iol In Cataract Surgery.

Currently available multifocal intraocular lenses (IOLs) often present limitations in terms of subjective visual quality and patient satisfaction. This study aims to assess the visual performance and patient-reported outcomes following implantation of the new LuxLife™ full range-of-vision IOL (Bausch + Lomb) in patients undergoing cataract surgery. The innovative, nondiffractive optical design of this lens is intended to enhance visual comfort while providing a continuous range of vision.

Preliminary single-center study at a tertiary ophthalmology institution.

This is a prospective, descriptive, single-center study. Cataract surgery with LuxLife IOL implantation was performed in 50 patients (90 eyes), aged 65–85 years. Inclusion criteria was an axial length of 22.5-24.5 mm, correctable corneal astigmatism, mesopic pupil diameter of 3–4 mm, and absence of significant ocular comorbidities. Only eyes achieving a postoperative spherical equivalent within ±0.50 D of the targeted refraction were included for analysis. Monocular and binocular UCVA and CDVA were evaluated at far, intermediate, and near distances at 1 week, 2 months, and 4–6 months postoperatively. PROMs were assessed using the Catquest-9SF questionnaire. 

Postoperatively at 1 week, 2 months, and 4–6 months, monocular and binocular UCVA and CDVA showed effective visual performance across far, intermediate, and near distances in LuxLife™ eyes. Catquest-9SF PROMs revealed high spectacle independence, minimal illumination dependence, strong satisfaction across distances, and low dysphotopsia incidence. 

LuxLife™ IOL provides effective full-range vision with excellent objective and subjective outcomes in selected patients, warranting larger, longer-term comparative prospective studies.​